Back to results
US 2026/0207693 A1Published application
Application of Shenling Baizhu in Preparation of Medicine for Treating Neuropsychiatric Symptoms of Recovered COVID-19 Patients
AssigneeBeijing Redsun Pharmaceutical Co.,Ltd.
InventorDeliang LIN
Life of this patent
Estimating the term…
Abstract
An application of Shenling Baizhu in the preparation of a medicine for treating neuropsychiatric symptoms of recovered COVID-19 patients.
Claims10
Use of Shenling Baizhu in the preparation of a medicine for treating neuropsychiatric symptoms of recovered COVID-19 patients, wherein the raw material composition of the Shenling Baizhu comprises:
- ginseng, rhizoma atractylodis macrocephalae stir-fried with bran, poria cocos, Chinese yam, lotus seed, fried white hyacinth beans, coix seed, fructus amomi, platycodon grandiflorus, and liquorice.
A method for treating neuropsychiatric symptoms of recovered COVID-19 patients, wherein the method comprises administering a therapeutically effective amount of Shenling Baizhu to a subject suffering from post-COVID-19 neuropsychiatric symptoms,
- wherein the raw material composition of the Shenling Baizhu comprises:
- ginseng, rhizoma atractylodis macrocephalae stir-fried with bran, poria cocos, Chinese yam, lotus seed, fried white hyacinth beans, coix seed, fructus amomi, platycodon grandiflorus, and liquorice.
Dependencies are inferred from the claim text.